TNF and inflammatory bowel disease: The treatment used for IBD was 5-ASA in 34 patients (70.8%), corticosteroids in 12 (25.0%), IM in 13 (27.1%), CNI in 1 (2.1%), anti-TNF antibody in 5 (10.4%), JAK inhibitor in 2 (4.2%), VDZ in 1 (2.1%), cytapheresis in 1 (2.1%), CVC in 3 (6.3%), and bowel resection in 4 (8.3%).